about
Development of human neutralizing monoclonal antibodies for prevention and therapy of MERS-CoV infectionsNonneutralizing Antibodies Induced by the HIV-1 gp41 NHR Domain Gain Neutralizing Activity in the Presence of the HIV Fusion Inhibitor Enfuvirtide: a Potential Therapeutic Vaccine Strategy.Crystal Structures of Yeast-Produced Enterovirus 71 and Enterovirus 71/Coxsackievirus A16 Chimeric Virus-Like Particles Provide the Structural Basis for Novel Vaccine Design against Hand-Foot-and-Mouth Disease.Development of therapeutics for treatment of Ebola virus infection.Virus-like particles for enterovirus 71 produced from Saccharomyces cerevisiae potently elicits protective immune responses in mice.
P50
description
investigador
@es
researcher
@en
name
Haoyang Li
@en
type
label
Haoyang Li
@en
prefLabel
Haoyang Li
@en
P31
P496
0000-0003-3024-1350